Abstract
The extent to which the food industry shows tendencies to converge with the pharmaceutical industry are explored in the context of the implications for innovation management and the role of open innovation in particular. Convergence is identified as the blurring of boundaries between industries by converging value propositions, technologies and markets. The effects of increasing health care costs as well as a greater consumer interest in preventing diseases by making distinctive food choices are shown to be central reasons for an ongoing process of industry convergence at the intersection of the pharmaceutical and the food industry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
